Merck & Co., Inc. (NEO:MRK)
19.03
+0.75 (4.10%)
Apr 25, 2025, 4:00 PM EDT
Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of CAD 288.54 billion. The enterprise value is 322.68 billion.
Market Cap | 288.54B |
Enterprise Value | 322.68B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
Earnings Date | Apr 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.30% |
Shares Change (QoQ) | -0.24% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.51B |
Valuation Ratios
The trailing PE ratio is 11.51.
PE Ratio | 11.51 |
Forward PE | n/a |
PS Ratio | 3.14 |
PB Ratio | 4.33 |
P/TBV Ratio | 24.26 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 12.88 |
EV / Sales | 3.64 |
EV / EBITDA | 7.94 |
EV / EBIT | 9.47 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.83 |
Debt / EBITDA | 1.31 |
Debt / FCF | n/a |
Interest Coverage | 19.34 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 19.29% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 1.24M |
Profits Per Employee | 338,632 |
Employee Count | 75,000 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 20.10 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 49.22 |
Average Volume (20 Days) | 10,047 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.34 |
Income Statement
In the last 12 months, Merck & Co. had revenue of CAD 91.88 billion and earned 25.06 billion in profits. Earnings per share was 9.89.
Revenue | 91.88B |
Gross Profit | 71.04B |
Operating Income | 35.33B |
Pretax Income | 28.99B |
Net Income | 25.06B |
EBITDA | 41.64B |
EBIT | 35.33B |
Earnings Per Share (EPS) | 9.89 |
Balance Sheet
The company has 19.68 billion in cash and 55.01 billion in debt, giving a net cash position of -35.33 billion.
Cash & Cash Equivalents | 19.68B |
Total Debt | 55.01B |
Net Cash | -35.33B |
Net Cash Per Share | n/a |
Equity (Book Value) | 66.65B |
Book Value Per Share | 26.34 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 77.32%, with operating and profit margins of 38.46% and 27.27%.
Gross Margin | 77.32% |
Operating Margin | 38.46% |
Pretax Margin | 31.55% |
Profit Margin | 27.27% |
EBITDA Margin | 45.32% |
EBIT Margin | 38.46% |
FCF Margin | n/a |
Dividends & Yields
Merck & Co. does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.30% |
Shareholder Yield | 0.30% |
Earnings Yield | 8.68% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |